ZYBERNO
Stock Report
Updated Sep 1, 2026

INTERNATIONAL STEM CELL CORPORATION (ISCO)

Healthcare • OTC

$0.38

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
12.0/100
POOR BUSINESS
INTERNATIONAL STEM CELL CORPORATION (ISCO) scores 12/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-4.7%)
Return on Capital (Capital Efficiency):CRITICAL (-8.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

INTERNATIONAL STEM CELL CORPORATION (ISCO) stock report — Zyberno Score 12/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, ISCO generated -$159.00K in Owner Earnings. Capital was deployed as follows: $61.00K invested in capital expenditures.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.38
Market Cap:$3.06M

Valuation Multiples (2)

P/S Ratio:0.32x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$2.37M

Price Action & Momentum (3)

Momentum Percentile:62 / 100
% of 52-Week High:70.8%
B. Profitability Assessment

Margin Analysis (3)

Operating Margin Ttm:-4.7%
Net Margin Ttm:-6.1%
Ebitda Margin:-2.9%

TTM Performance (3)

Gross Margin Ttm:55.0%
Operating Margin Ttm:-4.7%
Net Margin Ttm:-6.1%

Yield Metrics (2)

Earnings Yield:-$20.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-159.3%
Latest Earnings Filed:2026-08-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):6.8%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):20.8%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-34.6%
Operating Cash Flow Growth Rate (Linear):-19.5%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):92.4%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.79x
Quick Ratio:0.45x
Cash Ratio:0.22x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-1.89x
Times Interest Earned:-1.89

Capital Structure (4)

Working Capital:-1,064,000.00
Cash And Cash Equivalents:1,089,000.00
Long Term Debt:$199.00K
Net Debt:-$691.00K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $9.51M
Linear Growth: 6.8%
📊 Click to view full ISCO Revenue analysis & methodology →
Cost Of Revenue Ttm:$4.29M

Profitability Breakdown (2)

Gross profit TTM: $5.23M
Linear Growth: 5.1%
📊 Click to view full ISCO Gross Profit analysis & methodology →
Operating income TTM: -$444.00K
Linear Growth: 92.4%
📊 Click to view full ISCO Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$582.00K
Linear Growth: 20.8%
📊 Click to view full ISCO Net Income analysis & methodology →
Income Before Tax:-$2.21M
Ebitda Ttm:-272,000.00

Operating Expenses (5)

Operating Expenses:9,958,000.00
R And D Expense:646,000.00
Sga Expense:3,919,000.00
Income Tax Expense:$0.00
Interest Expense:141,000.00

Expense Ratios (3)

R And D To Revenue Percentage:24.1%
Sga To Revenue Percentage:146.5%
Ebitda Margin:-2.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$5.06M
Current Assets:$3.92M
Ppe Net:2,524,000.00
Goodwill:0.00
Intangible Assets:$515.00K

Liability Structure (4)

Total Liabilities:9,284,000.00
Current Liabilities:4,984,000.00
Long Term Debt:$199.00K
Short Term Debt:$199.00K

Equity & Capital (3)

Equity:-$4.23M
Retained Earnings:-$111.39M
Common Stock:120,000,000.00

Working Capital Items (3)

Accounts Receivable:959,000.00
Inventory:1,685,000.00
Accounts Payable:969,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:59,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$98.00K
Linear Growth: -19.5%
Free cash flow TTM: -$159.00K
Linear Growth: -34.6%
📊 Click to view full ISCO Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$31.00K
Capital Expenditures Ttm:61,000.00

Financing Activities (3)

Financing Cash Flow:-$150.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:172,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.07
-$0.07
Earnings Per Share Ttm:-$0.07

Revenue & Cash Per Share (2)

Sales Per Share Ttm:1.19
Operating Cash Flow Per Share:$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.53
Cash Per Share:0.14

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.88x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:9.92x
Days Sales Outstanding Ttm:36.79

Inventory Management (2)

Inventory Turnover Ttm:2.54x
Days Inventory Outstanding Ttm:143.53

Payables & Cash Cycle (2)

Days Payable Outstanding:82.54
Cash Conversion Cycle:97.78
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$159.00K
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):6.8%
Net Income Growth Rate (Linear):20.8%
Operating Income Growth Rate (Linear):92.4%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-34.6%
Operating Cash Flow Growth Rate (Linear):-19.5%

Other Growth Rates (1)

Gross Profit Growth Rate (Linear):5.1%
C. Company Profile & Context

Corporate Information (6)

Symbol:ISCO
Company Name:INTERNATIONAL STEM CELL CORPORATION
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.00M
Shares Outstanding Basic:8.00M
Shares Outstanding Diluted:8.00M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 21:58:23 UTC
Data Timestamp:2026-08-22T15:51:24.466891
Scroll to Top